Effective chimeric antigen receptor T cells against SARS-CoV-2

Summary: Current therapies to treat coronavirus disease 2019 (COVID-19) involve vaccines against the spike protein S1 of SARS-CoV-2. Here, we outline an alternative approach involving chimeric antigen receptors (CARs) in T cells (CAR-Ts). CAR-T recognition of the SARS-CoV-2 receptor-binding domain (...

Full description

Saved in:
Bibliographic Details
Main Authors: Xueyang Guo, Alexandra Kazanova, Stephanie Thurmond, H. Uri Saragovi, Christopher E. Rudd
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
Q
Online Access:https://doaj.org/article/92a1ae3a31c64365ad85696fa463ec73
Tags: Add Tag
No Tags, Be the first to tag this record!